Evidence map›Paper›PMID 33908052›Full record

ArticlePacing and clinical electrophysiology : PACE2021

Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid-19 lockdown.

Michele Magnocavallo, Alessia Bernardini, Marco Valerio Mariani, Agostino Piro, Massimiliano Marini, Antonino Nicosia, Carmen Adduci, Antonio Rapacciuolo, Davide Saporito, Stefano Grossi and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Pacing and clinical electrophysiology : PACE, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. HeartLogic™: real-world data-efficiency, resource consumption, and workflow optimization.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  5. Article
  6. Article
  7. A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2022
    Review
  8. Article
  9. The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
  10. Review
  11. Review
  12. Remote Monitoring of CIEDs-For Both Safety, Economy and Convenience?International journal of environmental research and public health · 2021
    Review
  13. Point-of-care testing, your cardiologist, and affairs of the heart.Cardiovascular digital health journal · 2021
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michele MagnocavalloDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Alessia BernardiniDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Marco Valerio MarianiDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Agostino PiroDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Massimiliano MariniDepartment of Cardiology, S. Chiara Hospital, Trento, Italy.
Antonino NicosiaCardiology Unit, Giovanni Paolo II Hospital, Ragusa, Italy.
Carmen AdduciDivision of Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, St. Andrea Hospital, Rome, Italy.
Antonio RapacciuoloCardiology Unit, Università degli Studi di Napoli Federico II, Naples, Italy.
Davide SaporitoDivision of Cardiology, Infermi Hospital, Rimini, Italy.
Stefano GrossiCardiology Department, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy.
Giuseppe SantarpiaDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
Paola VaccaroCardiology Unit, Riuniti Hospital, P.O. Cervello, Palermo, Italy.
Roberto RordorfDepartment of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Francesco PentimalliCardiology Unit, San Paolo Hospital, Savona, Italy.
Giuseppe GiuntaDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Monica CampariBoston Scientific, Milan, Italy.
Sergio ValsecchiBoston Scientific, Milan, Italy.
Carlo LavalleDepartment of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the COVID-19 pandemic in-person visits for patients with cardiac implantable electronic devices should be replaced by remote monitoring (RM), in order to prevent viral transmission. A direct home-delivery service of the RM communicator has been implemented at 49 Italian arrhythmia centers.

methodsAccording to individual patient preference or the organizational decision of the center, patients were assigned to the home-delivery group or the standard in-clinic delivery group. In the former case, patients received telephone training on the activation process and use of the communicator. In June 2020, the centers were asked to reply to an ad hoc questionnaire to describe and evaluate their experience in the previous 3 months.

resultsRM was activated in 1324 patients: 821 (62%) received the communicator at home and the communicator was activated remotely. Activation required one additional call in 49% of cases, and the median time needed to complete the activation process was 15 min [25th-75th percentile: 10-20]. 753 (92%) patients were able to complete the correct activation of the system. At the time when the questionnaire was completed, 743 (90%) communicators were regularly transmitting data. The service was generally deemed useful (96% of respondents) in facilitating the activation of RM during the COVID-19 pandemic and possibly beyond.

conclusionsHome delivery of the communicator proved to be a successful approach to system activation, and received positive feedback from clinicians. The increased use of a RM protocol will reduce risks for both providers and patients, while maintaining high-quality care.

Indexed as

Defibrillators, ImplantableHome Care ServicesPhysical DistancingArrhythmias, CardiacCOVID-19FemaleHumansIncidenceItalyMalePacemaker, ArtificialPandemicsPneumonia, ViralRemote Sensing TechnologySARS-CoV-2cardiac implantable electronic devicecovid-19follow-upremote monitoring

Identifiers

PMID33908052
PMCPMC8207054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.